The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical outcomes with early-elective discontinuation of PD-1 inhibitors (PDi) at one year in patients (pts) with metastatic melanoma (MM).
 
Rebecca Pokorny
Employment - Walgreens (I); Walgreens (I)
Stock and Other Ownership Interests - Amneal Pharmaceuticals (I); Immunogen; Immunogen (I)
 
Jordan P. McPherson
No Relationships to Disclose
 
Kenneth F. Grossmann
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Bristol-Myers Squibb (I); Castle Biosciences; Novartis; Roche/Genentech
 
Carolyn Luckett
No Relationships to Disclose
 
Benjamin Newell Voorhies
No Relationships to Disclose
 
Daniel S. Sageser
No Relationships to Disclose
 
Jocelyn Wallentine
No Relationships to Disclose
 
Zachary Tolman
No Relationships to Disclose
 
Siwen Hu-Lieskovan
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Genmab; Guidepoint Global; Merck
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Neon Therapeutics (Inst); Vaccinex (Inst); Xencor (Inst)
 
Umang Swami
No Relationships to Disclose